BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...partner and general counsel. Fliss was the general counsel of TPG Capital, TPG’s private equity arm.Novacyt S.A....
...the board at Radius Health Inc. (NASDAQ:RDUS). Jessica Hopfield and Tony Rosenberg stepped down from the board. BC Staff Nektar PureTech Novacyt Checkmate...
BioCentury | Mar 25, 2020
Product Development

Bruker-Novacyt, PerkinElmer launch COVID-19 diagnostics; plus Nuclein speeds development its PCR test

...Bruker Corp. (NASDAQ:BRKR) announced the European launch of a COVID-19 test from Primerdesign Ltd., a Novacyt S.A....
BioCentury | Mar 22, 2020
Regulation

FDA authorizes first COVID-19 point-of-care diagnostic

...week. On Monday, FDA issued an Emergency Use Authorization for a separate COVID-19 diagnostic from Novacyt S.A....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...NASDAQ:RXDX) 10/19/17 $160.0 $1,060.1 $1,771.2 67% Akari Therapeutics plc (NASDAQ:AKTX) 10/18/17 $17.4 $76.3 $66.1 -13% Novacyt S.A....
BioCentury | Nov 3, 2017
Financial News

Novacyte raises EUR9.7M placing

...On Oct. 18, Novacyt S.A. (Euronext:ALNOV; LSE:NCYT) raised €9.7 million ($11.3 million) through the sale of 14.7...
...14.7 million shares at €0.66 in an unconditional direct subscription and a conditional placing. Separately, Novacyt...
...and new and existing French investors participated in the fundraising. Novacyt S.A. (Euronext:ALNOV; LSE:NCYT), Velizy-Villacoublay, France Jennie Walters Novacyt S.A....
BioCentury | Jun 13, 2016
Financial News

Novacyt completes private placement

Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2016-06-02 Type: Private placement Raised: EUR1.4 million ($1.6 million) Shares: 1 million Price: EUR1.40 Shares after offering: 14 million Investor: Existing investor WIR Staff...
BioCentury | May 2, 2016
Financial News

Novacyt completes convertible bond financing

...bond financing Raised: EUR750,000 ($844,050) Shares outstanding prior: 10 million Investor: Yorkville Advisors LLC Note: Novacyt...
BioCentury | May 2, 2016
Financial News

Novacyt completes private placement

...placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 10 million Note: Novacyt...
BioCentury | Apr 11, 2016
Financial News

Novacyt completes private placement

...placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 8.6 million Note: Novacyt...
...of a private placement. The company plans to complete a second tranche by April 22. Novacyt...
...million ($3.4 million). The three-year bond bears 12.5% interest and will be drawn down when Novacyt...
BioCentury | Mar 7, 2016
Company News

Primerdesign, Novacyt deal

...company Primerdesign for L5 million ($7.1 million) in cash and L4.9 million ($7 million) in Novacyt...
...identification and bio-threat detection. Novacyt markets its NovaPrep liquid-based cytology screening platform for cancer detection. Novacyt...
...and Novacyt had EUR8.9 million ($9.7 million) in 2015 sales. Primerdesign Ltd. , Southampton, U.K. Novacyt S.A....
Items per page:
1 - 10 of 28
BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...partner and general counsel. Fliss was the general counsel of TPG Capital, TPG’s private equity arm.Novacyt S.A....
...the board at Radius Health Inc. (NASDAQ:RDUS). Jessica Hopfield and Tony Rosenberg stepped down from the board. BC Staff Nektar PureTech Novacyt Checkmate...
BioCentury | Mar 25, 2020
Product Development

Bruker-Novacyt, PerkinElmer launch COVID-19 diagnostics; plus Nuclein speeds development its PCR test

...Bruker Corp. (NASDAQ:BRKR) announced the European launch of a COVID-19 test from Primerdesign Ltd., a Novacyt S.A....
BioCentury | Mar 22, 2020
Regulation

FDA authorizes first COVID-19 point-of-care diagnostic

...week. On Monday, FDA issued an Emergency Use Authorization for a separate COVID-19 diagnostic from Novacyt S.A....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...NASDAQ:RXDX) 10/19/17 $160.0 $1,060.1 $1,771.2 67% Akari Therapeutics plc (NASDAQ:AKTX) 10/18/17 $17.4 $76.3 $66.1 -13% Novacyt S.A....
BioCentury | Nov 3, 2017
Financial News

Novacyte raises EUR9.7M placing

...On Oct. 18, Novacyt S.A. (Euronext:ALNOV; LSE:NCYT) raised €9.7 million ($11.3 million) through the sale of 14.7...
...14.7 million shares at €0.66 in an unconditional direct subscription and a conditional placing. Separately, Novacyt...
...and new and existing French investors participated in the fundraising. Novacyt S.A. (Euronext:ALNOV; LSE:NCYT), Velizy-Villacoublay, France Jennie Walters Novacyt S.A....
BioCentury | Jun 13, 2016
Financial News

Novacyt completes private placement

Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2016-06-02 Type: Private placement Raised: EUR1.4 million ($1.6 million) Shares: 1 million Price: EUR1.40 Shares after offering: 14 million Investor: Existing investor WIR Staff...
BioCentury | May 2, 2016
Financial News

Novacyt completes convertible bond financing

...bond financing Raised: EUR750,000 ($844,050) Shares outstanding prior: 10 million Investor: Yorkville Advisors LLC Note: Novacyt...
BioCentury | May 2, 2016
Financial News

Novacyt completes private placement

...placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 10 million Note: Novacyt...
BioCentury | Apr 11, 2016
Financial News

Novacyt completes private placement

...placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 8.6 million Note: Novacyt...
...of a private placement. The company plans to complete a second tranche by April 22. Novacyt...
...million ($3.4 million). The three-year bond bears 12.5% interest and will be drawn down when Novacyt...
BioCentury | Mar 7, 2016
Company News

Primerdesign, Novacyt deal

...company Primerdesign for L5 million ($7.1 million) in cash and L4.9 million ($7 million) in Novacyt...
...identification and bio-threat detection. Novacyt markets its NovaPrep liquid-based cytology screening platform for cancer detection. Novacyt...
...and Novacyt had EUR8.9 million ($9.7 million) in 2015 sales. Primerdesign Ltd. , Southampton, U.K. Novacyt S.A....
Items per page:
1 - 10 of 28